MYCOTIC KERATITIS.
Grover
A D
AD
Institute of Ophthalmology, Muslim University, Aligarh, India.
Agarwal
K C
KC
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification*; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D017613:Iodine Compounds / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D014005:Tinea / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D014249:Trichophyton / Q000302:isolation & purification*
D000935:Antifungal Agents; D017613:Iodine Compounds; D009761:Nystatin; D000086:Acetazolamide; D010118:Oxytetracycline